| Human rhinoviruses SE Jacobs, DM Lamson, K St. George, TJ Walsh Clinical microbiology reviews 26 (1), 135-162, 2013 | 861 | 2013 |
| Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single‐centre study … DE Corzo‐León, MJ Satlin, R Soave, TB Shore, AN Schuetz, SE Jacobs, ... Mycoses 58 (6), 325-336, 2015 | 128 | 2015 |
| Candida auris pan-drug-resistant to four classes of antifungal agents SE Jacobs, JL Jacobs, EK Dennis, S Taimur, M Rana, D Patel, M Gitman, ... Antimicrobial agents and chemotherapy 66 (7), e00053-22, 2022 | 70 | 2022 |
| Colonization with levofloxacin-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae and risk of bacteremia in hematopoietic stem cell transplant recipients MJ Satlin, KD Chavda, TM Baker, L Chen, E Shashkina, R Soave, ... Clinical Infectious Diseases 67 (11), 1720-1728, 2018 | 68 | 2018 |
| DAS181 for treatment of parainfluenza virus infections in hematopoietic stem cell transplant recipients at a single center M Salvatore, MJ Satlin, SE Jacobs, SG Jenkins, AN Schuetz, RB Moss, ... Biology of blood and marrow transplantation 22 (5), 965-970, 2016 | 65 | 2016 |
| Impact of prophylactic levofloxacin on rates of bloodstream infection and fever in neutropenic patients with multiple myeloma undergoing autologous hematopoietic stem cell … MJ Satlin, S Vardhana, R Soave, TB Shore, TM Mark, SE Jacobs, ... Biology of Blood and Marrow Transplantation 21 (10), 1808-1814, 2015 | 64 | 2015 |
| Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients SE Jacobs, R Soave, TB Shore, MJ Satlin, AN Schuetz, C Magro, ... Transplant Infectious Disease 15 (5), 474-486, 2013 | 54 | 2013 |
| Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy SE Jacobs, DM Lamson, R Soave, BH Guzman, TB Shore, EK Ritchie, ... Journal of Clinical Virology 71, 51-58, 2015 | 44 | 2015 |
| Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of … AR Mato, SM Luger, DF Heitjan, ME Mikkelson, E Olson, C Ujjani, ... Cancer Biology & Therapy 9 (8), 585-589, 2010 | 44 | 2010 |
| Novel antifungal agents in clinical trials SE Jacobs, P Zagaliotis, TJ Walsh F1000Research 10, 2021 | 39 | 2021 |
| Treatment with convalescent plasma in solid organ transplant recipients with COVID‐19: experience at large transplant center in New York City F Rahman, STH Liu, S Taimur, S Jacobs, T Sullivan, D Dunn, E Baneman, ... Clinical transplantation 34 (12), e14089, 2020 | 37 | 2020 |
| Mucormycosis in hematopoietic cell transplant recipients and in patients with hematological malignancies in the era of new antifungal agents MA Miller, KC Molina, JA Gutman, S Scherger, JM Lum, SB Mossad, ... Open Forum Infectious Diseases 8 (2), ofaa646, 2021 | 27 | 2021 |
| Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID‐19) AD Santeusanio, MC Menon, C Liu, A Bhansali, N Patel, F Mahir, M Rana, ... Clinical transplantation 35 (4), e14221, 2021 | 26 | 2021 |
| Non-Aspergillus hyaline molds: emerging causes of sino-pulmonary fungal infections and other invasive mycoses SE Jacobs, NL Wengenack, TJ Walsh Seminars in Respiratory and Critical Care Medicine 41 (01), 115-130, 2020 | 26 | 2020 |
| Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: case report and review of the literature SE Jacobs, D Saez-Lacy, W Wynkoop, TJ Walsh Open Forum Infectious Diseases 4 (2), ofx040, 2017 | 22 | 2017 |
| Predisposition or protection? COVID-19 in a patient on LVAD support with HIV/AIDS K Mahmood, ER Rashed, E Oliveros, VQ Chau, T Hermle, S Jacobs, ... Case Reports 2 (9), 1337-1341, 2020 | 20 | 2020 |
| HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles T Muthukumar, C Afaneh, R Ding, D Tsapepas, M Lubetzky, S Jacobs, ... Transplantation 95 (5), 711-720, 2013 | 18 | 2013 |
| Disseminated Mycobacterium marinum infection in a hematopoietic stem cell transplant recipient S Jacobs, A George, GA Papanicolaou, ME Lacouture, BH Tan, ... Transplant Infectious Disease 14 (4), 410-414, 2012 | 18 | 2012 |
| Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies A Mato, BD Fuchs, D F. Heitjan, R Mick, SD Halpern, PD Shah, S Jacobs, ... Cancer biology & therapy 8 (12), 1095-1100, 2009 | 18 | 2009 |
| Efficacy of intravenous immunoglobulin for preventing infections in patients with multiple myeloma G Lancman, K Lozada, N Athar, S Jacobs, J Doucette, HJ Cho, ... Clinical Lymphoma Myeloma and Leukemia 21 (5), e470-e476, 2021 | 16 | 2021 |
